Clinical Trials and Cancer Survival Analysis

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 116卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：272 / 272
页数：1
相关论文
共 50 条
  • [41] The impact of young age on survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program
    Lieu, C.
    Renfro, L.
    De Gramont, A.
    Maughan, T. S.
    Seymour, M. T.
    Saltz, L.
    Goldberg, R. M.
    Sargent, D.
    Eckhardt, S. G.
    Eng, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S483 - S483
  • [42] "Standard Care" in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trials
    Dear, Rachel F.
    McGeechan, Kevin
    Barnet, Megan B.
    Barratt, Alexandra L.
    Tattersall, Martin H. N.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (09): : 1131 - 1139
  • [43] Analysis of recruitment of patients into clinical trials for colorectal cancer
    Joubert, Richard
    Thomas, Moehler
    Raeth, Ulrich
    CANCER RESEARCH, 2011, 71
  • [44] Clinical trials in pancreatic cancer: A comprehensive analysis.
    Katayama, Erryk Stephan
    Hue, Jonathan J.
    Bajor, David Lawrence
    Ocuin, Lee Mayer
    Ammori, John Brian
    Hardacre, Jeffrey
    Winter, Jordan Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Propofol and survival: an updated meta-analysis of randomized clinical trials
    Kotani, Yuki
    Pruna, Alessandro
    Turi, Stefano
    Borghi, Giovanni
    Lee, Todd C. C.
    Zangrillo, Alberto
    Landoni, Giovanni
    Pasin, Laura
    CRITICAL CARE, 2023, 27 (01)
  • [46] Multiple random change points in survival analysis with applications to clinical trials
    Xu, Jianbo
    STATISTICAL PAPERS, 2024, 65 (07) : 4267 - 4298
  • [47] Survival analysis - An alternative approach to applying data in clinical trials.
    Hannigan, A
    JOURNAL OF DENTAL RESEARCH, 1996, 75 (05) : 1242 - 1242
  • [48] Propofol and survival: an updated meta-analysis of randomized clinical trials
    Yuki Kotani
    Alessandro Pruna
    Stefano Turi
    Giovanni Borghi
    Todd C. Lee
    Alberto Zangrillo
    Giovanni Landoni
    Laura Pasin
    Critical Care, 27
  • [49] Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials”
    Manuel Alberto Guerrero Gutierrez
    José A. Meade-Aguilar
    Diego Escarraman Martinez
    Critical Care, 27
  • [50] DISCUSSION OF SESSION-1 - CLINICAL-TRIALS, SURVIVAL ANALYSIS
    FISHER, LD
    STATISTICS IN MEDICINE, 1992, 11 (14-15) : 1881 - 1885
12345